NasdaqGS - Nasdaq Real Time Price USD

Health Catalyst, Inc. (HCAT)

Compare
8.39 +0.16 (+1.94%)
At close: September 26 at 4:00 PM EDT
Loading Chart for HCAT
DELL
  • Previous Close 8.23
  • Open 8.36
  • Bid 8.38 x 200
  • Ask 8.41 x 200
  • Day's Range 8.11 - 8.42
  • 52 Week Range 5.42 - 11.41
  • Volume 711,575
  • Avg. Volume 564,652
  • Market Cap (intraday) 507.345M
  • Beta (5Y Monthly) 1.32
  • PE Ratio (TTM) --
  • EPS (TTM) -1.49
  • Earnings Date Oct 31, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 10.85

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

www.healthcatalyst.com

1,300

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HCAT

View More

Performance Overview: HCAT

Trailing total returns as of 9/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HCAT
9.40%
S&P 500
20.45%

1-Year Return

HCAT
14.74%
S&P 500
32.46%

3-Year Return

HCAT
84.38%
S&P 500
28.95%

5-Year Return

HCAT
75.10%
S&P 500
92.48%

Compare To: HCAT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HCAT

View More

Valuation Measures

Annual
As of 4/4/2024
  • Market Cap

    507.35M

  • Enterprise Value

    447.76M

  • Trailing P/E

    --

  • Forward P/E

    21.79

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.63

  • Price/Book (mrq)

    1.42

  • Enterprise Value/Revenue

    1.50

  • Enterprise Value/EBITDA

    -4.96

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -28.87%

  • Return on Assets (ttm)

    -6.58%

  • Return on Equity (ttm)

    -23.15%

  • Revenue (ttm)

    299.48M

  • Net Income Avi to Common (ttm)

    -86.45M

  • Diluted EPS (ttm)

    -1.49

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    308.26M

  • Total Debt/Equity (mrq)

    69.66%

  • Levered Free Cash Flow (ttm)

    27.76M

Research Analysis: HCAT

View More

Company Insights: HCAT

Research Reports: HCAT

View More

People Also Watch